The story of Viagra and the pharmaceutical industry presents a intricate picture for prospective investors. Initially, copyright's remarkable drug transformed the treatment of erectile dysfunction, producing substantial profits and influencing the current pharmaceutical landscape. However, intellectual property expiration and the rise of generic ve